NovaBay Pharmaceuticals Completes Enrollment in Phase 2 Impetigo Clinical TrialNovaBay Pharmaceuticals Completes Enrollment in Phase 2 Impetigo Clinical Trial. New Class of Anti-infectives Addresses Rising Tide of Antibiotic Resistance. Smith-Midland Corp (OTC BB: SMID) Management InterviewSmith-Midland Corp EcoloCap Solutions Inc (OTC BB: ECOS) CEO InterviewEcoloCap Solutions Inc Kona Grill (NASDAQ: KONA) CEO InterviewKona Grill Eastmain Resources (TSX: ER) CEO InterviewEastmain Resources Terrane Metals Corp (TSX.V: TRX) CEO InterviewTerrane Metals Corp JBI, Inc. Completes Private PlacementJBI, Inc. has completed a private placement with a total of 488,779 shares sold at $4.00 per share. Cogent Communications (NASDAQ: CCOI) CEO InterviewCogent Communications Aldrin Resource Corp (TSX.V: ALN) CEO InterviewAldrin Resource Corp PuraMed BioScience (OTC BB: PMBS) CEO InterviewPuraMed BioScience |
|
Standard Podcast: 
WSR Recommends |
||
| Special Deal for Our Readers (That’s You!) | Jim Cramer: The Clown That Makes You Money | Get Rich with Fibonacci. Learn How to Use Fibonacci Analysis to Trade Better. |
